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Abstract 
This cross-sectional study observed the association of smoke exposure and tuberculosis-
related outcomes in Saskatchewan by individuals who had been exposed to someone with 
infectious TB. This study is unique in that we were quantifying the amount of smoke exposure 
that increases susceptibility to TB infection and/or active TB.  Subjects who were at least 18 
years old were enrolled into the study because they were contacts to infectious tuberculosis.  The 
study involved a detailed interview.  This interview involved questions on demographics, hair 
treatment (specifically, hair dying), tobacco smoke exposure, co-morbidities/risk factors, and 
alcohol consumption.  After the interview was conducted, a small 10mg sample of hair was 
collected from each individual.  This was to ensure a more accurate level of smoke exposure was 
attained.  In total, 104 individuals were recruited to participate in this study.  Linear regression 
analysis was used to compare cigarette consumption and nicotine concentration.  A quadratic 
term was added to the linear model and the result was that reported cigarette consumption per 
day (x) was significantly associated with nicotine concentration (y) where y=0.91+1.35x-0.25x2 
(p=0.001).  A Fisher’s exact test was conducted to see if there was a relationship between 
smoking and TB disease; there was no statistically significant association between TB disease 
and smoking (OR= 3.28, 95%CI 0.37-29.1, p = 0.24).  Logistic regression analysis was used to 
see if there was a relationship between smoking and TB infection.  Of the five predictor 
variables, none were statistically significant.  Smokers had an association with higher odds of TB 
infection (OR=2.03, 95%CI 0.71-5.80, p=0.19).  Canadian-born Aboriginals had an association 
with lower odds of TB infection (OR=0.52, 95%CI 0.18-1.46, p=0.21).  The results from this 
study could provide insight into creating a larger, more complex study involving TB and 
smoking. 
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Chapter One: Introduction 
1.1 Study Rationale 
 
Tuberculosis (TB), a highly complex infectious disease, continues to be a major 
threat worldwide.  The World Health Organization (WHO) estimates that it is the second 
leading cause of death from infectious disease, after the Human Immunodeficiency Virus 
(HIV) (1).  The WHO approximates that there were 8.6 million new TB cases in 2012, 
along with 1.3 million deaths from TB.  Death from TB can be largely avoided with 
proper access to health care and treatment.  About 90% of cases can be treated with first-
line drugs that have been available for decades (1).  
 In 2011, the incidence of tuberculosis in Saskatchewan was 7.5 per 100,000 
population, which was significantly higher than the Canadian incidence of 4.7 per 
100,000 population (2).  One mechanism, smoking, has been singled out as a risk factor 
to contracting TB.  A high prevalence of tobacco use has been noted since the early 20th 
century in studies looking for risk factors for tuberculosis.  Despite numerous medical 
advances with tuberculosis, only a limited number of studies have examined the effect 
that active and passive smoking may have on contracting TB infection and progression to 
TB disease. 
 
1.2 Study Purpose 
 The purpose of this study is to observe the association of smoke exposure and 
tuberculosis-related outcomes in Saskatchewan. This study is unique because it examines 
hair samples from individuals who have been exposed to someone with infectious TB.  
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This will allow us to compare and analyze the amount of nicotine found in hair samples 
with smoking history. We hope to be able to see if this has an impact on whether or not 
someone is more likely to contract a TB infection and/or possibly progress to TB disease.  
The objective is to support deeper understanding of how smoke exposure affects initial 
infection and development of TB.  The results may be able to improve methods within 
TB control to prioritize individuals who have been in contact with infectious TB. 
 
1.3 Research Objectives 
 The objective of this research is to investigate the following research questions: 
I. Is there a relationship between nicotine concentration and self-reported cigarette 
consumption? 
II. Among individuals who have a TB infection, do smokers have a higher chance of 
developing active tuberculosis than non-smokers?  
IIIa. Are smokers more prone to TB infection than non-smokers? 
IIIb. Do Canadian-born Aboriginals have a higher chance of having a TB infection? 
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Chapter Two: Literature Review 
2.1 Tuberculosis 
 Tuberculosis (TB) is a complex infectious disease that has affected humans for thousands 
of years.  TB is caused by mycobacteria belonging to the Mycobacterium tuberculosis complex.  
Despite being first identified by Robert Koch in the late 19th century, Mycobacterium 
tuberculosis is still a leading cause of death in low and middle-income countries (1). 
 Currently, Mycobacterium tuberculosis is one of the world’s most lethal pathogens; it is 
estimated that one-third of the world’s population is infected with this micro-organism (1).  The 
World Health Organization (WHO) estimates that in 2012, there were 8.6 million incident cases 
of TB globally (equivalent to 137 cases per 100,000 population)(1).  In 2009, there were 
approximately 14 million prevalent cases of TB disease (equivalent to 200 cases per 100,000 
population (3).  There were an estimated 1.6 million deaths due to TB in 2009, making it the 
second leading cause of death by an infectious disease in the world (3).  The large majority of the 
cases (95%) are in the developing world, where resources and treatments are scarce.  The spread 
of the human immunodeficiency virus (HIV) and the emergence of drug-resistant TB strains 
threaten to make some cases incurable (4).  Both an increase of susceptibility in HIV patients and 
the emergence of drug-resistant strains have put an enormous burden on health care, forcing 
health professionals to re-think existing methods of prevention, diagnosis and treatment (4). 
 Tuberculosis occurs through one main pathway: acquisition of infection followed by 
progression to disease.  Infected individuals are not always ill or infectious, but there is a 10% 
chance infected individuals will develop TB disease.  Individuals who are infected with TB, but 
do not have the disease are described as having a latent TB infection (LTBI).  Individuals who 
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have TB disease are described as having active tuberculosis and may spread the disease to other 
people (4).       
 There are many factors which aid in the development in TB; these are known as risk 
factors.  Some of these factors include HIV/AIDS, Canadian-born Aboriginal status, alcohol use, 
tobacco smoking, and low socioeconomic status (overcrowding in houses, lower income, lower 
level of education) (4;5).  
HIV plays a major role in the acquisition and development of TB.  The Public Health 
Agency of Canada (PHAC) defines the Human Immunodeficiency Virus (HIV) as a virus that 
specifically targets and attacks the immune system.  HIV leaves individuals with a chronic and 
progressive illness, where the human immune system becomes vulnerable to infections and 
cancers (6).  Specifically, HIV targets the key part of an individual’s immune system, known as 
the CD4 cells.  The HIV virus attacks the CD4 cells by invading them, using the CD4 cells to 
make more copies of the HIV virus, and then eventually  destroys the CD4 cells (7).  Once the 
CD4 count falls below a certain number, the body can no longer fight infections and diseases.  
When this occurs, the HIV infection can progress to AIDS, which stands for Acquired 
Immunodeficiency Syndrome (6).  AIDS is the final stage of HIV and can result in death if 
proper treatment is not sought.  HIV is an infectious agent, which is transmitted person to person 
through the individual’s bloodstream.  HIV can be transmitted from unprotected sexual 
intercourse, shared needles, unsterilized needles, pregnancy, delivery and breast feeding, and 
occupational exposure in health care settings (6).   
Tuberculosis is one of the leading causes of death among people living with HIV and 
HIV is one of the strongest risk factors for developing TB disease (8).  People living with HIV 
are 30 times more likely to develop TB than people without HIV (9).  According to the World 
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Health Organization, in 2012 1.1 million of new TB cases worldwide were HIV-positive (9).   
South Africa is one of the most affected countries because 73% of all TB cases are HIV-positive 
(8).  It is important to highlight the significance of the relationship between TB and HIV when 
looking at a population. 
 
2.2 Tuberculosis Pathogenesis 
 TB disease indicates the presence of current active tuberculosis that is usually 
symptomatic.  This is usually defined by either a laboratory confirmed case or a clinically 
confirmed case (4).  Transmission of TB occurs by aerosolized droplets generated by a cough in 
persons with active disease, that when inhaled by other individuals,  infection may be established 
(10).  When infected people cough, sneeze, or even talk, they propel the mycobacteria into the 
air.  To cause an infection, a certain number of mycobateria need to be inhaled.  Nevertheless, 
not all people who inhale these droplets will get an infection or even get sick.   Approximately 
10% of individuals infected with M. tuberculosis end up developing TB disease (11) .  Latent 
tuberculosis infection (LTBI) is defined as infection without either laboratory or clinical 
evidence of disease (10).  LTBI means the individual is infected with M. Tuberculosis, but the 
mycobacteria is dormant (not growing) and there is no evidence of clinically active disease (12).  
Latent tuberculosis is defined by an immunologic test; the tuberculin skin test or mantoux test 
(TST) is the standard diagnostic tool for TB infection. The TST is an intradermal injection of 
tuberculin administered into the forearm to determine if a person has a reaction to tuberculin 
antigen.  A reaction to this test is interpreted to mean that the individual has been exposed to and 
infected with M. Tuberculosis.  It is also important to note that not all infected persons will 
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produce a positive result.  The reasons for false-negative reactions are an inability to react to skin 
tests because of a weakened immune system, recent TB infection, very old TB infection, very 
young age, recent live-virus vaccination, and incorrect method of TST administration and/or 
interpretation of result (13).  Conversely, a person may produce a false positive reaction due to 
several reasons.  These reasons include, but are not limited to: infection with nontuberculosis 
mycobacteria, previous BCG vaccination, incorrect method of TST administration and/or 
interpretation of result (13). 
 Probability of transmission increases with the following factors: frequency and severity 
of cough in the individual infected with tuberculosis disease, duration of exposure, proximity to 
the source case (the individual infected with tuberculosis disease), crowding and poor room 
ventilation, and delays in diagnosis and/or effective treatment (4).   
  The state in which the host is able to control the infection, but not completely eradicate 
the mycobacteria is a representation of equilibrium within the human body (10).  The greatest 
threat to individuals with a latent infection occurs when the immune response fails in some way 
and the infection reactivates to cause active disease (14).  In most cases, the host’s immune 
system is strong enough to forestall active tuberculosis for a lifetime (14). 
 Tuberculosis is ordinarily classified as pulmonary and non-pulmonary.  Pulmonary 
disease means the tuberculosis is in the lungs and conducting airways.  In pulmonary TB, which 
accounts for most cases of TB, the smear positive patient is considered to spread the infection via 
an airborne route (15).   In less common cases, smear negative pulmonary TB cases can transmit 
infection to others (12).  The term non-pulmonary or extrapulmonary tuberculosis is used to 
describe the occurrence of TB at sites other than the lung (16).  Non-pulmonary TB means the 
infection can be found in any organs, including the bones, kidneys and meninges of the brain 
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(15).  Non-pulmonary TB will not transmit infection to other people.   
 
2.3 Epidemiology of Tuberculosis 
 
Most Canadians have a low chance of developing active tuberculosis disease.  In Canada, the 
incidence was 4.78 per 100,000 population in 2012 (17).  The highest rate in the country was 
reported in Nunavut, which had a rate of 184.4 per 100,000 population, more than 28 times the 
national rate (18).  Statistics from 2012 highlight that 64% of all reported TB cases in Canada 
were foreign-born individuals.   Canadian-born Aboriginal cases make up approximately 23% of 
all reported cases in the country, even though they comprise only 3.8% of Canada’s population 
(17).  The TB rate in Canadian-born Aboriginals remains the highest of any of the Canadian born 
groups, being almost 6 times greater than the Canadian average (18). 
 In 2011, the rate of TB in Saskatchewan was 7.5 per 100,000 population, which was 
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significantly higher than the 2011 Canadian rate (4.7 per 100,000 population), as illustrated in 
Figure 1(2).   
 
 
Figure 1. Tuberculosis rate in Saskatchewan and Canada between 2000 and 2011  
This figure illustrates the differences between Saskatchewan and Canada.  It is clear that SK has a higher rate of TB 
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than Canada from 2000-2011.  Rate per 100,000 is shown on the Y-axis and the year is shown on the X-axis. 
(Source: Saskatchewan TB prevention and control program) 
In Saskatchewan, Canadian-born Aboriginals made up nearly 77% of new cases in 2011, 
whereas foreign-born individuals made up nearly 19% of new cases.  The rate of active TB in 
Canadian-born Aboriginals is clearly illustrated in Figure 2.   
 
Figure 2. Rate of active TB disease in Canadian-born Aboriginals per province/territory in 
Canada in 2010 
This figure shows the rate of TB per 100,000 on the Y-axis and the rate per province/territory on the X-axis.  
Manitoba, Saskatchewan, and the Northern territories have high TB rates in the Canadian-born Aboriginal 
population.  Newfoundland, Prince Edward Island, Nova Scotia and New Brunswick all have extremely TB rates in 
the Canadian-born Aboriginal population. (Source: Public Health Agency of Canada, TB Control Standards, 7 th 
edition) 
Saskatchewan, Manitoba, and the Northern Territories have the same characteristic, a high active 
TB rate in the Canadian-born Aboriginal population.   
 
2.4  Tobacco Smoking 
 
Tobacco is a plant that is native to North and South America (19).  It is estimated 
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that as early as 1 B.C., American Indians began using tobacco in religious ceremonies and part of 
medicinal practices (20).  In the 15th century, Christopher Columbus was offered dried tobacco 
leaves from the American Indians.  Shortly after, tobacco was brought to Europe and the plant 
was grown all over the world (19).  Tobacco was thought to be a cure to most ailments that 
affected people.  As the popularity of tobacco grew, so did its affiliation with politics and 
finances (21).  The lands where tobacco was produced became highly valuable territories, 
attracting individuals who wanted to make their fortunes, even if it meant living in dangerous 
conditions (21). 
The tobacco smoking pandemic arose at the beginning of the 19th century, when tobacco   
was being produced commercially throughout the world (22).  The birth of the modern cigarette 
was in 1913, when RJ Reynolds introduced the Camel brand (19).  The rise of the manufactured 
cigarette meant an enormous increase in smokers across the world.  It is estimated that, at the 
beginning of the 21st century, about one third of the world used tobacco (19).  Currently, it is 
thought that nearly a fifth of the world’s population smokes tobacco or uses tobacco products 
(23).    
The most common form of tobacco smoking is cigarettes, but there are many other types 
of products that contain tobacco: pipe tobacco, cigars, cigarillos, sniff, and snus.  Tobacco is a 
plant that are composed of many chemicals including nicotine, chlorophyll, and water (24).  The 
tobacco plant is harvested when it is ripe and the leaves are dried (24).  When the leaves begin to 
dry, this process is known as curing.  There are three main methods of curing.  The first method 
is known as flue-curing, which means the tobacco leaves are dried in an enclosed building that 
contains a heat source (24).  The second method involves the tobacco leaves dry in an open-
frame building, but are protected from wind and sun: this method is known as air-curing.  The 
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last method is known as sun-curing, which means the tobacco leaves are dried under the rays of 
the sun.  Once the tobacco leaves are cured, they are sold to a processor.  The processor then 
shreds the tobacco and assembles it into a paper filter to produce a cigarette.  Tobacco is one of 
many ingredients that are added to a finished cigarette.  There are approximately 600 ingredients 
in a single cigarette (25).   
Tobacco contains a drug called nicotine (26).  When a cigarette is smoked, it can take as 
little as 10 seconds for nicotine to reach the brain (27).  This causes three main reactions in the 
human body: heart rate and blood pressure increase, blood vessels constrict, and muscles relax 
(27).  Nicotine works by imitating acetylcholine, a naturally-occurring neurotransmitter in the 
human brain (28).   
Tobacco smoke contains thousands of chemicals including 43 known carcinogens (29).  
It is estimated that tobacco smoke contains more than 4,000 compounds in different chemical 
states (22).  There are many known health effects that environmental tobacco smoke exposure 
causes in both active and passive smokers: lung cancer, heart disease, bronchitis.  Tobacco 
smoke leads to more deaths than any other significant cause, such as alcohol, car accidents, and 
AIDS (22).   
There are two main ways people are exposed to tobacco smoke: either they are actively 
smoking by inhaling tobacco smoke into the lungs (known as active smokers) or they are 
indirectly inhaling the air in which tobacco smoke is present (known as passive smokers) (22).   
2.4.1 Measuring Smoke Exposure 
 
 There are many ways of measuring smoke exposure.  Many studies have examined 
smoke exposure simply by self-reporting tobacco use.  Due to the well-documented negative 
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effects of tobacco use, one study suggested active smokers are likely to under-report their 
tobacco use (reporting bias) (30).  Nevertheless, one survey conducted by Statistics Canada 
noted that self-reporting data on smoking status provided a valid estimate of the prevalence of 
smoking in Canada (31).  One study suggests using a biomechemical validation of self-reported 
tobacco use to decrease distortion between self-reported cigarette consumption and actual 
cigarette consumption (32).  To account for this, this study looked at both nicotine levels in hair 
and self-reported tobacco use to estimate how much smoke an individual was exposed to.     
 
2.5  Epidemiology of Tobacco Smoking 
 
 The World Health Organization believes that tobacco use continues to be the leading 
global cause of preventable death, while costing hundreds of billions of dollars of economic 
damage each year (33).  The WHO  estimates that smoking causes 9% of deaths worldwide (34).  
It is estimated that nearly 1.3 billion people smoke tobacco products (34).  Most of these people 
live in low or middle income countries, where the burden of TB is very high.   
Tobacco continues to kill six million people each year and an additional 600,000 non-
smokers who die from second-hand smoke exposure (35).  If current trends continue, the WHO 
estimates that, in the 21st century, tobacco will be the cause of over a billion deaths worldwide 
(33).    
In 1999, 25.2% of Canadians were considered current smokers.  In 2012, approximately 
16.1% or 4.6 million Canadians were current smokers (36).  This trend is representative of the 
past 50 years in Canada; in the mid 1960’s, over 60% of Canadians were current smokers, which 
is over three times as many smokers as there are now.     
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The 2013 Canadian tobacco report suggests there were 3.4 million daily smokers (11.9%) 
and 1.2 million non-daily smokers (4.2%).  Smoking was highest among young adults aged 20-
24 (20.3%) and 25-34 (21.8%).  It also appears that smoking is more prevalent in males (18.4%) 
than females (13.9%) (37). 
 Among the Canadian provinces, Newfoundland had the highest smoking rate with a 
prevalence of 19.7%, while British Columbia had the lowest smoking rate at 13.2%.  The daily 
average cigarette consumption (cigarettes per day, CPD) ranged from 15.8 in Ontario to 12.9 in 
British Columbia.  Approximately 18.5% of Saskatchewan residents were smokers in 2012, 
above the 2012 national average of 16.1% (36).  On average, Saskatchewan consumed 13.8 
cigarettes per day.  This is a decrease from the 2011, where 19.2% of Saskatchewan residents 
were current smokers and the average cigarettes consumed per day was 14.8.  According to 2008 
data, the lowest smoking rates in Saskatchewan were found in Cypress (21.1%) and the highest 
smoking rates were found in Mamawetan/Keewatin/Athabasca (41.3%), Sunrise (26.9%) and 
Sun Country (29.9%) (38). 
 In 2009, it was estimated that tobacco use costed the Saskatchewan economy in $167.6 
million in direct health care costs; it was also estimated that tobacco use costed $535.2 million in 
indirect costs, such as loss in productivity and short-term disability (38).  There are numerous 
additional costs tobacco use costs the Saskatchewan economy.  The full cost of tobacco use in 
Saskatchewan in 2008 was estimated at $1.08 million.  Only a small fraction (18%) of these 
costs was offset through tobacco tax revenue.  About 34% of the cost was covered by 
Saskatchewan employers and 48% was covered by tax payers. 
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2.6  Smoking and Tuberculosis 
 
Smoking has long since been identified as an increased risk for both TB infection and TB 
disease.  In 1842, Chadwick noted “tuberculosis thrives in deprived bodies: its allies are 
undernourishment, debilitation, unventilated living and working accommodation, squalor, and 
smoking” (39).  Following Chadwick’s statement, doctors and researchers formed an opinion 
that tobacco smoking caused inflammation in the lungs, which increased the opportunity for 
bacterial infection (40).  This led them to believe that smokers were at a higher risk for 
tuberculosis infection and disease. We now recognize the greater susceptibility of smokers to TB 
reflects three main factors: smoking damages the lungs, which makes individuals more 
susceptible to TB infection; smoking harms the immune system, which makes individuals less 
likely to combat TB infection; and smoking reduces the effectiveness of TB treatments, which 
could result in longer periods of infection or more severe disease (41).  Research has shown that 
both active and passive smoking can affect how someone becomes infected with TB bacteria and 
how the infection progresses to TB disease (42-44). 
 There have been a number of researchers that have found that active smoking increases 
susceptibility to tuberculosis (42;43;45).  One study concluded that tobacco smoking was 
associated with a twofold increased risk of active tuberculosis in a general Taiwanese population 
(42).  According to Basu et al., smoking increases the risk of latent tuberculosis by 1.9, active 
tuberculosis by 2.0, and death from tuberculosis by 2.6, after adjusting for socioeconomic status 
(23).  The same study presented a mathematical model projecting that a total of 113 million 
tuberculosis cases and 88 million deaths from tuberculosis would be attributable to smoking 
between 2010 and 2050 (23).  One systematic review and meta-analysis conducted looked at 
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several variables, including tobacco smoking as an implicated risk factor for TB infection, 
disease and death.  They found that there is consistent evidence that tobacco smoking is 
associated with an increased risk of TB (46).  The increased risk of latent TB for smoking 
compared with non-smoking is illustrated thoroughly in this article.  The meta-analysis 
specifically looked at 1 case control study and 5 cross-sectional studies, all of which showed an 
increased risk of latent TB infection for smoking compared with non-smoking.  The odds ratio 
for all these studies ranged from 1.72 to 3.2, with very narrow confidence intervals.  This 
conveys that a significant, positive relationship was found in all of the studies.  One of the 
study’s weaknesses was that they did not control for antigen exposure.  This would provide key 
insight by analyzing how much antigen individuals were exposed to, which would either increase 
or decrease their risk of contracting a latent TB infection. 
 Passive smoking has also been analyzed by researchers as a risk factor for TB.  One study 
concluded that passive exposure to tobacco smoke within the household was found to be an 
independent predictor of the development of active TB among a cohort of never-smoking 
married women aged 65 to 74 years (44).  They also stated that passive smoking accounted for 
13.7% of active TB cases in this cohort.  One meta-analysis also examined the impact of passive 
smoking on developing TB disease.  They found that passive smoke exposure substantially 
increased the risk of developing TB disease compared with non-exposure.  The meta-analysis 
specifically looked at case control studies in adults and in children.  It found that the risk of 
clinical TB disease for passive smoking exposure was significant when compared to non-
exposure.  In fact, the studies looking at children and passive smoking found very high odds ratio 
with very narrow confidence intervals.  This means that there is a positive and significant 
relationship between passive smoking and risk of clinical TB disease. 
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 Although smoking cessation has not been as widely researched, one study offered some 
interesting insight.  This study looked at smokers in China who had already been diagnosed with 
TB.  They found that smokers had a very high TB mortality, almost as high as nine times than 
those who had never smoked.  Upon smoking cessation, the risk reduced significantly and was 
similar with those who never had smoked (47).  This study estimated that the TB mortality rate 
reduced nearly 65% when people quit smoking (44). 
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Chapter Three: Methodology 
3.1  Study Design 
 
This study is a cross-sectional study.  The population used for this study were individuals 
in Saskatoon, Saskatchewan who had been in contact with someone with infectious tuberculosis.  
The samples that were drawn from this population were all over the age of 18 and had been 
labelled “at-risk” because they were exposed to infectious TB.  In total, 104 subjects were 
recruited and many variables were assessed.  An interview and hair sample was collected with 
each subject who agreed to participate in the study.  The interview was composed of questions 
on demographics, risk factors/co-morbidities, and alcohol consumption.  Subjects were at least 
18-years-old and were enrolled into the study because they were contacts to an infectious 
tuberculosis case.  According to the Saskatchewan TB Prevention and Control Program, a 
contact is defined as “individuals who have breathed the same indoor air ten hours or more one 
month prior to the date of diagnosis of a person with [infectious] tuberculosis; the emphasis is on 
the time and proximity of exposure” (12). 
 
3.2  Setting and Population 
 
The setting for this study was the city of Saskatoon, Saskatchewan’s most populous urban 
centre, with an estimated population of 246,300 as of June 30th, 2013 (48).  The study population 
were individuals who were a contact of someone with infectious tuberculosis.  Subjects would 
either be seen in the TB control clinic in the Royal University Hospital or outside the hospital in 
Saskatoon.  Participants were collected between July 2012 and August 2013.  Individuals who 
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were excluded from the study was anyone under the age of 18.   
 
3.3  Ethics Approval 
 
 This study was initially approved by the Biomedical Review Ethics Board at the 
University of Saskatchewan in June of 2011.  Amendments were made to add Kelsey Seal as a 
co-investigator in summer of 2012.  A second amendment was made in late spring 2013, 
allowing the co-investigator(s) to follow the nurse conducting contract traces outside of the 
hospital. 
   
3.4  Data Collection 
 
As previously mentioned, data collection took place both inside the Royal University 
Hospital and in the field, with somewhat different subpopulations associated with each of these 
venues.  As part of their standard contract tracing process, TB control personnel notified any 
contacts that have been in close proximity with an individual with diagnosed TB disease.  
Contacts are usually tested in one of two ways: either these individuals are called to the TB 
Control clinic to receive a TST or the public health nurse may also venture into the field to test 
using TSTs.  There are certain all day clinics in TB control where the TB doctor meets with 
individuals who either have LTBI or TB disease.   
     As part of data collection, the Master’s student would come to the clinic days and attend field 
clinics.  The TB nurse would let the Master’s student know when they were venturing out into 
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the field to plant1 TST’s or holding a clinic day.  While planting TST’s, the nurse would tell the 
possible participant about the study and if they were interested, they could participate after their 
TST was read (approximately 48 hours after the TST was planted).  This was to ensure that the 
TB control program would have their TST result and that information required for the study 
would be collected.  If their reaction measured 5mm or more, they were considered to have a 
positive TST; this is the accepted practice amongst TB health professionals (4).  Once their 
results had been read by the TB nurse and they were marked as a potential participant, the nurse 
would then briefly explain the study.  If the participant conveyed their interest and agreed to the 
study, the Master’s student was introduced to the participant. Informed consent was then sought 
by signing the participant information and consent form.  After the consent form was read and 
signed by the participant, the first component of the study involved a detailed interview.  This 
interview involved questions on demographics (age, education level, ethnicity, housing 
situation), hair treatment (hair dying), tobacco smoke exposure, co-morbidities/risk factors, liver 
disease, and alcohol consumption.  After the interview was conducted, the Master’s student took 
a small (approximately 10mg) sample of the patient’s hair.  The hair was extracted with a set of 
scissors and was cut as close to the scalp as possible.  The hair was placed in a marked envelope, 
sealed, and stored in a secure area.  The envelopes had a number placed on them to ensure the 
participants remained anonymous to everyone but the Master’s student.  The participant was then 
thanked for their time and an incentive was given to cover basic expenses (such as time and/or 
cost of travel). 
                                                 
 
1 To “plant” is to administer an injection.  
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3.5  Hair as a Biomarker to Measure Smoke Exposure 
 
Biomarkers are becoming a standard for measuring environmental tobacco smoke 
exposure, as they avoid many sources of bias (49).  A biomarker is defined as a biological 
molecule used to measure signs of a normal or abnormal process in the human body (50).  Doses 
of exposure to environmental smoke are calculated by the analysis of toxic substances in 
biological specimens (22).  There are two main types of monitoring exposure: real-time 
monitoring, which determines exposure at any given instant, and which evaluates trace 
substances in samples of blood, urine, saliva, breast milk, and placenta, and long-time 
monitoring, which determines exposure over a long period of time and which evaluate 
substances in hair, bones, liver, and fatty tissue (22).   
Urine cotinine is one of the more widely used biomarkers to measure environmental 
tobacco smoke exposure.  Measuring urine cotinine has its disadvantages, which include 
variability in cotinine excretion levels for similar tobacco exposures and a short half-life of 20 
hours (49).   
Hair nicotine is acknowledged as a more accurate biomarker of environmental tobacco 
smoke exposure than urine cotinine.  Although cotinine is present in hair, it exists at much lower 
concentrations than nicotine.  The lower cotinine level in hair can make it extremely difficult to 
differentiate between active and passive smoke exposure groups (49).  Nicotine is incorporated 
into hair if it is present in the circulation and contamination of nicotine is minimal after washing 
samples (51).  Alternatively, some scientists argue that nicotine is mainly absorbed into the hair 
from the ambient environment (52).  Advantages of using hair nicotine as a biomarker include its 
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capacity to record longer-term exposure patterns, collection ease, storage at room temperature 
without degradation for up to 5 years, and shipment without any necessary precaution (51). 
One study noted that self-reported tobacco use was better correlated with salivary 
cotinine levels than hair nicotine levels.  Moreover, a survey conducted by Statistics Canada 
found a significant association between urinary cotinine and self-reported cigarette consumption.  
This is probably because salivary cotinine represents relatively recent exposure levels, as 
opposed to hair nicotine which is a longer-term biomarker (30). 
Hair nicotine has been established as an effective biomarker to determine tobacco smoke 
exposure.  The most popular way to measure nicotine in hair is high-performance liquid 
chromatography (HPLC).  This is found to be a cheaper and easier means of measuring nicotine 
in hair compared to the alternatives (53). 
Hair samples were collected by cutting hair from the base of the scalp and storing the hair 
in paper envelopes.  The hair was submerged in different chemicals for a specific period of time.  
The samples were then inserted into a tube using a machine called an electronic balance and then 
washed for 90 minutes in a solvent called dicholoromethane.  The samples were then dried.  The 
hair was then digested by placing the samples in tubes of sodium hydroxide.  Nicotine was 
extracted from the digest with diethyl ether.  The nicotine was measured using an 
electrochemical detector (53). 
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3.6  Variables 
 
 In this study, several variables were analyzed.  The following is a complete list of 
variables used:  
TB information 
 TST Result: The TST is used to see if an individual has been infected with TB.  A 
positive test (meaning exposure was detected) is defined as an induration that is 5 mm or 
more in diameter; this measurement is the Canadian Standard for contacts to infectious 
tuberculosis and used by the Saskatoon Health Region. This continuous variable was 
obtained through the Tuberculosis Information Database.  Every patient that is given a 
TST has their results entered into the Tuberculosis Information Database, regardless 
whether there is a positive or negative outcome. 
 TB Disease: This categorical variable was obtained through the TB database.  It is a 
variable that is also recorded in the database as “Yes” or “No”. 
Demographics 
 Participant seen in the Clinic or Field: This dichotomous variable was determined at the 
time of interview.   
 Date of Birth: Birth date was the first question asked in the interview, but could also be 
found using the TB data base.  It is a continuous variable.  
 Age at the time of Interview: This is a continuous variable that was obtained during the 
interview.  In this study, no one under the age of 18 was recruited. 
 Gender: Gender was a dichotomous question asked on the interview.   
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 Ethnicity: This categorical variable was obtained through the interview.  There were five 
possible ethnicities that could be selected: Canadian-born Aboriginal (comprised of 
Métis, Inuit, and First Nation), Canadian-born Non-Aboriginal, and Foreign-born. 
 Education Level: Education level was one of the first categorical questions asked on the 
interview.  There were three choices: elementary, secondary, and university/college.  
 Hair Treatment: Everyone who was interviewed was asked if they had dyed their hair in 
the past 6 months.  This is because hair dye can have a significant impact on nicotine 
concentration in the strands of hair.  This is a categorical variable. 
 How much do you smoke: This categorical variable was obtained through the interview.  
There were three possible choices: daily, less than daily, and never. 
 Have you smoked daily in the past: Anyone who answered “less than daily” or “never” to 
the question “how much do you smoke?” was asked “have you ever smoked daily in the 
past?”  This variable is dichotomous.  
 How long since you last had a cigarette: This continuous question was asked to 
individuals who said they were daily smokers in the past, but are not currently daily 
smokers.   
 How old were you when you first started smoking: This continuous question was obtained 
through the interview. 
 How many cigarettes do you smoke a day: Anyone who said they were a daily or less 
than daily smoker was asked this continuous question.   
 How often are you exposed to the tobacco smoke of others: This categorical question was 
presented to everyone in the study.  There were five possible answers: not at all, a few 
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times per day on some days, many times per day on some days, a few times per day on 
most days, and many times per day on most days. 
 Do you use smokeless tobacco: This categorical question was asked of everyone.  There 
were three possible answers: daily, less than daily, or not at all. 
 How many rooms other than closets/bathrooms/storage space are there in your current 
dwelling: This continuous variable was asked to get an idea about overcrowding.  It was 
followed by the next continuous question: How many people in total currently reside in 
your dwelling? 
Co-Morbidities/Risk Factors 
 Have you ever been diagnosed with a liver condition including hepatitis, liver cirrhosis, 
cancer, and jaundice: This dichotomous question was asked from everyone.  If the 
participant responded “yes”, they were asked what specific condition they had. 
 Have you ever been diagnosed with diabetes: This dichotomous question was asked of 
everyone.  If the participant responded with “yes”, they were asked what type of diabetes 
they had and how old they were when they were first diagnosed with diabetes.   
 Have you ever been diagnosed with a kidney disease: This dichotomous question 
followed any questions about diabetes.  If the participant answered “yes”, they were 
asked what condition they had. 
 Have you been diagnosed or been informed by a health professional that you have any 
other health conditions such as high blood pressure, heart problems, chronic bronchitis, 
chronic obstructive pulmonary disease: This question is dichotomous and it was asked of 
everyone.  If someone responded “yes” to the question, they were asked what specific 
condition they had. 
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Alcohol Consumption 
 During the past 12 months, have you had a drink of beer, wine, liquor or any other 
alcoholic beverage: This dichotomous question was asked of everyone.  If someone 
responded no, the interview would end here. 
 During the past 12 months, how often did you drink alcoholic beverages: This categorical 
question had 7 possible answers: less than once a month, once a month, 2 to 3 times a 
month, once a week, 2 to 3 times a week, 4 to 6 times a week, or every day.  
 How often in the past 12 months have you had 5 or more drinks on one occasion: This 
categorical question had 6 possible answers: never, less than once a month, once a month, 
2 to 3 times a month, once a week, or more than once a week. 
 
3.7 Inclusion/Exclusion Criteria 
 
Anyone who was part of a contract trace between July 2012 and September 2013 were 
eligible for inclusion in this study.  Subjects had to have been in contact with someone who had 
infectious TB, putting the subjects at risk for contracting LTBI.  Additionally, anyone under the 
age of 18 was excluded from this study. 
Inclusion criteria: 
     i. Any person who was in contact with the index case (client with infectious TB, which lead to 
the investigation of contacts). 
     ii. Any person living in Saskatchewan. 
Exclusion criteria: 
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     i. Individuals who were under the age of 18 at the time of interview. 
     ii. Individuals who did not have enough hair to collect for an adequate sample. 
 
3.8 Data Analysis 
Univariate, bivariate, and multivariable data analyses were performed to satisfy each of 
the research questions.  All data was processed using SPSS 21.0 and Microsoft Excel. 
The difference in nicotine concentration between smokers and non-smokers was 
examined using a Wilcoxon Rank Sum test.  Nicotine Concentration between smokers/non-
smokers and individuals who dye their hair and do not dye their hair was also examined using a 
Kruskal Wallis test.  This was to see if hair dying had an impact on nicotine concentration. 
 
Research Question 1: Is there a relationship between self-reported cigarette consumption 
and nicotine concentration?  Linear regression was used to assess the relationship between 
cigarettes smoked per day and nicotine concentration in all study participants.  The association 
was examined to see if it met the linearity assumption and then the regression residuals were 
examined for normality, homogeneity of variance, and for the presence of extreme outliers and 
influential observations.  
Research Question 2: Among individuals who have a TB infection, do smokers have a 
higher chance of developing active tuberculosis than non-smokers?  Because of the 
extremely low number of people who developed active TB, a Fisher’s exact test was conducted. 
The relative risk and exact 95%confidence intervals were calculated using EpiInfo version 7.1.4 
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(Centers for Disease Control, Atlanta, Georgia). Due to the very small number of cases, there 
was no attempt to adjust for potential confounders. 
Research Question 3a: Are smokers more prone to TB infection than non-smokers? 
Research Question 3b: Do Canadian-born Aboriginals have a higher chance of having a TB 
infection?   One individual who had an unknown TST result was omitted from this analysis.  
Multivariable logistic regression approach was used to assess the association between smoking, 
Aboriginal status and the risk of a positive TST result for TB.  To begin, a series of univariate 
logistic regressions were conducted using TB infection as the outcome variable to screen 
potential risk factors of interest; variables associated with TB infection with p-values ≤ 0.25 
became candidates for multivariable modelling. TB infection (yes/no) was examined to see if it 
was unconditionally associated with several potential risk factors of interest: smoking (created as 
a dichotomous variable: non-smoker/smoker), aboriginal status (created as a dichotomous 
variable: Canadian-born Aboriginal/Non-Aboriginal), education (created as a dichotomous 
variable: elementary education/secondary and post-secondary education), housing density 
(created as a dichotomous variable: anything 0.5 (Canadian average (54)) or below people per 
room (PPR) was considered low density and anything above 0.5 PPR was considered high 
density), hair dye (created as a dichotomous variable: dyes their hair/does not dye their hair), 
alcohol consumption (created as a dichotomous variable: heavy alcohol consumption/light or no 
alcohol consumption, based on responses in the questionnaire on frequency and how much they 
drink), and gender (created as a dichotomous variable: female/male).  Age was examined as a 
continuous variable.  Housing density was calculated by dividing the number of individuals in a 
household by the number of rooms in living quarters, not including storage space and bathrooms.  
It is a density calculated in persons per room (PPR).   
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The variables that met the selection criterion at the first stage (p-value ≤ 0.25) were entered into 
the multivariable logistic regression model, along with variables which were of primary interest 
in the research question (smoking and aboriginal status) to form the preliminary main effects 
model. Variables with p-values ≤ 0.05 in the preliminary main effects model and the variables of 
primary interest were retained to form the main effects model.  Confounding was assessed by a 
sequential process that was carried out in order to assess the meaningful changes in beta 
coefficients. If the regression coefficient for the two variables of interest (smoking and 
Aboriginal status) changed by more than 10% when another risk factor was removed from the 
model, it was retained as a confounder.  Effect modification/interaction was then assessed by 
individually entering product terms into the main effects model.   Interaction terms were retained 
in the model if the p-value of the interaction term was < 0.05.  The combination of variables and 
interactions after this step formed the final model. 
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Chapter Four: Results 
4.1 Descriptive Statistics 
 
Out of the 104 individuals used for the study, the plurality self-identified themselves as 
Canadian-born Aboriginals (47%); 36 identified themselves as Canadian-born Non-Aboriginal 
(35%) and 19 (18%) identified themselves as Foreign-born.  Aboriginal peoples of Canada are 
indigenous people comprised of First Nations, Métis, and Inuit.   
Among all subjects, the prevalence of TB disease was 3.8% (4/104).  There were 4 cases 
of tuberculosis; all 4 cases of TB occurred in people who self-identified themselves as Canadian-
born Aboriginal.  Out of the 104 cases in the study, 57 (55%) individuals were TST negative, 46 
(44%) were TST positive and 1 (1%) case was unknown.  Among individuals who tested positive 
to the TST were 11 (24%) Canadian-born Non-Aboriginal, 19 (41%) Canadian-born Aboriginal, 
and 16 (35%) Foreign-born. 
Education level was another variable assessed in this study.  Nearly half (48%) of the 
people in this study had completed a secondary education. 
The youngest person in this study was 18 years old and the oldest person in this study 
was 72.  The mean age for this study was 31.7 years, with a median age of 30.1 (SD ± 13).  
There were 59 (57%) female and 45 (43%) male participants in this study. 
About 64 individuals (61%) reported smoking cigarettes daily and 40 individuals (39%) 
reported that they were non-smokers.  Among daily smokers, the mean of cigarettes smoked 
daily was 12, with a median of 10 (SD ± 9.2).  The least amount of cigarette(s) someone reported 
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smoking was 1 cigarette/day and the highest amount of cigarettes was 50 cigarettes/day.   For 
nicotine concentration among all participants, the mean was 7.2ng/mg with a median of 
1.6ng/mg (SD ± 12.6).  Nicotine concentration ranged from <0.04ng/mg to 58.97ng/mg.   
There were 5 cases of HIV in the population, 12 cases of HCV (Hepatitis C), and 5 cases 
of HIV/HCV.   
Alcohol consumption was another variable used in this study.  There were 27 people 
(27%) of the population who reported that they never consume alcohol.  There were 22 (21%) of 
individuals who said they consumed alcohol less than once a month, 16 (15%) of individuals 
who consumed alcohol once a month, 10 (9.5%) who said the drink alcohol 2-3 times a month, 4 
(4%) of individuals who consumed alcohol once a week, and 7 (7%) who said they drink alcohol 
more than once a week.   
Table 2.  List of variables in the study (n=104) 
  Number % of Population 
Ethnicity Canadian-born Aboriginal 
Canadian-born Non-
Aboriginal 
Foreign-born 
49 
36 
 
19 
47% 
35% 
 
18% 
TB Disease Yes 
No 
4 
100 
4% 
96% 
TST Result Positive 
Negative 
Unknown 
46 
57 
1 
44% 
55% 
1% 
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Education Level Elementary 
Secondary 
Post-Secondary 
28 
50 
26 
27% 
48% 
25% 
Age Under 25 
25-44 
45+ 
36 
47 
21 
35% 
45% 
20% 
Gender Female 
Male 
59 
45 
57% 
43% 
Cigarette Smoking Active Smokers 
Passive smokers 
Non-smokers 
64 
32 
8 
61% 
31% 
8% 
Comorbidities HIV/No HCV 
HCV (Hepatitis C)/No HIV 
HIV/HCV 
Neither HIV nor HCV 
5 
12 
5 
82 
5% 
12% 
5% 
79% 
Alcohol 
Consumption 
High Consumption 
Low Consumption 
31 
73 
29% 
71% 
Housing Density High  
Low 
80 
24 
77% 
23% 
Nicotine 
Concentration 
(ng/mg) 
High (10+ ng/mg) 
Moderate (2-10ng/mg) 
Low (Less than 2ng/mg) 
24 
25 
55 
23% 
24% 
57% 
 
Nicotine concentration was higher in smokers than in non-smokers (p=0.001) (Figure 3). 
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Figure 3. Comparison of nicotine concentration (ng/mg) between smokers and non-smokers 
(n=104)  
Smokers range: 0.026ng/mg-62.93ng/mg; Non-smokers range: 0.006ng/mg-4.68ng/mg 
 A comparison of nicotine concentration in non-smokers was also observed.  Individuals 
who reported they were exposed to secondhand smoke were classified as having passive smoke 
exposure.  Individuals who reported they were not exposed to secondhand smoke were classified 
as having no passive smoke exposure.  After visual inspection of a boxplot between these two 
groups in Figure 4, there appears to be substantial difference in nicotine concentration between 
individuals who are exposed to secondhand smoke and individuals who are not. 
Nicotine 
Concetration 
(ng/mg)
Nicotine Concentration Comparison Between Smokers and Non-Smokers
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Figure 4.  Nicotine Concentration Among Non-Smokers (n=39) 
Passive smoke exposure range: 0.01ng/mg-4.68ng/mg; No passive smoke exposure range: 0.01ng/mg-0.9ng/mg 
The difference between nicotine concentration in people reporting use of hair dye and no 
hair dye can be seen in Figure 5.  A Kruskal Wallis test showed that the differences between the 
groups were significantly different from each other (p=0.001).  A Wilcoxon test determined there 
was no significant difference between non-smokers who dyed their hair and non-smokers who 
did not die their hair (p=0.78), but there was a significant difference between smokers who dyed 
their hair and smokers who did not dye their hair (p=0.02).  
Nicotine 
Concentration 
(ng/mg)
Passive Smoke Exposure                                     No Passive Smoke Exposure
Nicotine Concentration Among Non-Smokers
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Figure 5.  Hair nicotine concentration compared between people who dye their hair and 
those who do not dye their hair (n=104) 
Non-smoker hair dye range: 0.006ng/mg-0.440ng/mg; Smoker hair dye range: 0.045ng/mg-20.374ng/mg 
Non-smoker no hair dye range: 0.01ng/mg-4.68ng/mg; Smoker no hair dye range: 0.026ng/mg-62.963ng/mg 
 
The mean housing density in this study was 1.12, the median was 1.00.  In figure 6, we 
see a boxplot comparing housing density among the different ethnicities.    
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Figure 6. Housing densities among different ethnicities measured in PPR (Persons Per 
Room) (n=104) 
Canadian-born Aboriginal range: 0.250PPR-4.500PPR;  
Canadian-born Non-Aboriginal range: 0.143PPR-4.0PPR; 
Foreign-born range: 0.40PPR-2.00PPR 
 
4.2 Research Questions 
Question 1: Is there a relationship between nicotine concentration and self-reported cigarette 
consumption? 
The association between nicotine concentration and cigarettes consumed per day was not linear.  
A quadratic term was added to the linear model and the result was that reported cigarette 
consumption per day (x) was significantly associated with nicotine concentration (y), where 
y=0.91+1.35x-0.25x2 (p=0.001). 
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Figure 7. Bivariate Scatterplot of Nicotine Concentration (ng/mg) vs. Cigarettes Consumed 
Per Day (n=104) 
 
Question 2: Among individuals who have a TB infection, do smokers have a higher chance of 
developing active tuberculosis than non-smokers? 
A Fisher’s exact test was conducted between smoking and TB disease as some expected cell 
frequencies were less than five, so a chi-square test could not be performed. There was no 
statistically significant association between TB disease and smoking (OR= 3.28, 95%CI 0.37-
29.1, p = 0.24). 
 
Question 3a: Are smokers more prone to TB infection than non-smokers? 
Question 3b: Do Canadian-born Aboriginals have a higher chance of having a TB infection? 
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Univariate logistic regression was used to identify potential risk factors unconditionally 
associated with TB infection with a p-value of < 0.25 for consideration in building the final 
multivariable model.   
Table 3.  Bivariate logistic regression between TB infection and select covariates (n=103) 
 Odds Ratio 95% Confidence Interval p value 
Smoking Status 
Smoker 
Non-Smoker 
 
1.52 
reference category 
 
0.68-3.38 
 
 
0.31 
Aboriginal status 
Aboriginal  
Non-Aboriginal 
 
0.57 
reference category 
 
0.26-1.25 
 
 
0.16* 
 
Education 
Elementary Education 
Secondary/Post-secondary Education 
 
1.73 
reference category 
 
0.72-4.2 
 
 
0.22* 
 
Housing Density 
Low Density 
High Density 
 
reference category  
1.11 
 
 
0.48-2.6 
 
 
0.80 
Hair Dying 
Hair Dye 
No Hair Dye 
 
3.27 
reference category 
 
1.29-8.24 
 
 
<0.05* 
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Alcohol Consumption 
Low/No Alcohol Consumption 
High Alcohol Consumption 
 
reference category 
1.90 
 
 
0.81-4.48 
 
 
0.14* 
Gender 
Female 
Male 
 
0.54 
reference category 
 
0.25-1.20 
 
 
0.13* 
Age (years) 1.00 0.97-1.03 0.87 
Nicotine Concentration (ng/mg) 1.00 0.97-1.03 0.98 
*= Statistically significant at α=0.25 
Education, hair dye, alcohol consumption, and gender were all retained for consideration in 
building the final multivariable model to estimate the association between aboriginal status and 
smoking on TB infection.  Smoking status was kept as the measure of smoke exposure, as it had 
a better fit with TB infection than nicotine concentration, as determined by the p-value.  Step 1 in 
developing the main effects multivariable model estimating the association between Aboriginal 
status and smoking on the risk of TB infection is summarized in Table 3.   
 
Table 4. Step 1 in developing the main effects model of potential risk factors for TB 
infection including reported smoking and Aboriginal status (n=103) 
 Adjusted Odds Ratio 95% Confidence Interval p value 
Smoking Status 
Smoker 
Non-Smoker 
 
2.08 
reference category 
 
0.73-6.00 
 
0.17 
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Aboriginal Status 
Aboriginal 
Non-Aboriginal 
 
0.50 
reference category 
 
0.18-1.43 
 
0.20 
Education 
Elementary Education 
Secondary/Post-Secondary Education 
 
2.71 
reference category 
 
0.93-7.90 
 
0.07 
Hair Dying 
Hair Dye 
No Hair Dye 
 
2.62 
reference category 
 
0.92-7.50 
 
0.07 
Alcohol Consumption 
Low/No Alcohol Consumption 
High Alcohol Consumption 
 
2.56 
reference category 
 
0.98-6.67 
 
0.06 
Gender 
Female  
Male 
 
0.74 
reference category 
 
0.29-1.89 
 
0.53 
*= Statistically significant at α=0.05 
The next step was omitting the variable which had the highest p-value, which was gender in this 
model. 
Table 5.  Step 2 in developing the main effects model of potential risk factors for TB 
infection including reported smoking and Aboriginal status (n=103) 
 Adjusted Odds Ratio 95% Confidence Interval p value 
 40 
 
Smoking Status 
Smoker 
Non-Smoker 
 
 
2.03 
reference category 
 
0.71-5.80 
 
0.19 
Aboriginal Status 
Aboriginal 
Non-Aboriginal 
 
0.52 
reference category 
 
0.18-1.46 
 
0.21 
Education 
Elementary Education 
Secondary/Post-Secondary Education 
 
2.79 
reference category 
 
0.96-8.08 
 
0.59 
Hair Dying 
Hair Dye 
No Hair Dye 
 
2.98 
reference category 
 
1.13-7.85 
 
0.28 
Alcohol Consumption 
Low/No Alcohol Consumption 
High Alcohol Consumption 
 
2.51 
reference category 
 
0.97-6.52 
 
0.59 
*= Statistically significant at α=0.05 
The next step was omitting alcohol from the model.  When omitting alcohol from the model, the 
regression coefficient for aboriginal/smoker changed more than 10%, so alcohol was kept in the 
model as a confounder.  The regression coefficient for aboriginal/smoker changed when 
removing both education and hair dying.  All three were considered to be confounders and 
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retained in the final model to ensure unbiased estimates of the association between smoking and 
Aboriginal status on the risk of TB. 
Table 6. Final main effects model examining the association between Aboriginal status and 
smoking with TB infection accounting for other potential risk factors (n=103) 
 Adjusted Odds Ratio 95% Confidence Interval p value 
Smoking Status 
Smoker 
Non-Smoker 
 
 
2.03 
reference category 
 
0.71-5.80 
 
0.19 
Aboriginal Status 
Aboriginal 
Non-Aboriginal 
 
0.52 
reference category 
 
0.18-1.46 
 
0.21 
Education 
Elementary Education 
Secondary/Post-Secondary Education 
 
2.79 
reference category 
 
0.96-8.08 
 
0.59 
Hair Dying 
Hair Dye 
No Hair Dye 
 
2.98 
reference category 
 
1.13-7.85 
 
0.28 
Alcohol Consumption 
Low/No Alcohol Consumption 
High Alcohol Consumption 
 
2.51 
reference category 
 
0.97-6.52 
 
0.59 
*= Statistically significant at α=0.05 
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Of the five predictor variables, none were statistically significant.  Smokers had an association 
with higher odds of TB infection (OR=2.03, 95%CI 0.71-5.80, p=0.19).  Canadian-born 
Aboriginals had an association with lower odds of TB infection (OR=0.52, 95%CI 0.18-1.46, 
p=0.21).  Smoking status, education, hair dying, and alcohol consumption all had extremely wide 
confidence intervals, meaning that the data may be too variable to elicit a precise estimate. 
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Chapter Five: Discussion 
5.1 Descriptive Statistics 
 
 The purpose of this cross-sectional study was to observe the association of smoke 
exposure and tuberculosis-related outcomes in Saskatchewan by using hair samples.  It examined 
104 individuals who had been in contact with an infectious TB case.  This study is unique 
because it examined hair samples to determine to how much smoke individuals were exposed.  
The majority of individuals were between the ages of 18 and 65; only one individual was over 
the age of 65. 
Only four individuals from this study had TB (3.8% of the population).  It is extremely 
important to note that three out of the four individuals who had Active TB were HIV positive.  
The reason this is important information is to consider is because HIV is one of the strongest risk 
for developing TB disease.  Further discussion on HIV in this study can be found in the 
limitations section of this document.  Nevertheless, all four individuals who developed TB 
disease were Canadian-born Aboriginal people.  This mirrors the patterns in the province of 
Saskatchewan: the majority of TB cases in the province occur among Canadian-born Aboriginal 
people (55).  Moreover, 3 of the 4 TB cases had developed the disease prior to the study.  This 
means we cannot make any definitive remarks on the development of active TB from smoke 
exposure; this is because prior knowledge regarding smoking status and other risk factors is 
unknown in these individuals.  
The difference in nicotine concentration between smokers and non-smokers was 
extremely large and statistically significant (p=0.001) (see Figure 4).  The majority of non-
 44 
 
smokers had a nicotine concentration below 1ng/mg, whereas most smokers had a nicotine 
concentration in the range 2-15ng/mg.  This supports the notion that smokers had more nicotine 
exposure than non-smokers, which was expected.  Moreover, non-smokers who reported to have 
passive smoke exposure had more nicotine concentration than non-smokers who reported to have 
no passive smoke exposure (Figure 3).   
Nearly half (49%) of women and 10% of men reported that they dyed their hair.  Because 
hair dye may have played a significant role in shaping nicotine concentration (see limitations 
section), the nicotine concentration between smokers and non-smokers for individuals who dyed 
their hair or did not dye their hair was compared (as seen in Figure 5).  There appears to be a 
significant difference between smokers who dyed their hair and did not dye their hair.  The range 
of nicotine concentration was much lower for individuals who dyed their hair.  The highest 
amount of nicotine found in smokers who did not dye their hair was just over 60ng/mg.  The 
highest amount of nicotine found in smokers who did dye their hair was just over 20ng/mg.  
Most of the smokers who dyed their hair fell between 1-12ng/mg, whereas most smokers who 
did not dye their hair fell between 4-19ng/mg.  A Wilcoxon test determined there was a 
significant difference between smokers who dyed their hair and smokers who did not dye their 
hair (p=0.02), meaning there was an association between hair dye and hair nicotine levels.  There 
was no significant association found between non-smokers who did not dye their hair and non-
smokers who did dye their hair.  This was expected because the nicotine concentration found in 
non-smokers was so low, hair dye would only have made a subtle impact.  It is possible that the 
difference between smokers who dyed their hair and did not dye their hair could be due to 
another variable at play.   For example, people who dye their hair may care more about 
appearances and wash their hair more; this may wash away any nicotine from the ambient 
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environment.  The difference could also be attributed to the impact of hair dye has on the hair 
shaft.  Hair dye damages the hair shaft, which could limit the amount of nicotine that is stored in 
the hair. 
  Information regarding housing density was also collected for this study because 
crowding is a risk factor for TB transmission (54).  According to a Canadian study, an increase 
of 0.1 persons per room increased the risk of two or more cases of TB in a community by 40% 
(56).  After calculating housing density in this study, approximately 66% of individuals were 
living in high density housing (having 0.7 persons per room or higher).  This is a significant 
portion of individuals to live in these conditions, especially because high density housing is a 
risk factor for TB.  Canadian-born Aboriginals are known to live in high density housing (57).  
Housing density among ethnicities was examined to see if our data reflected findings in the 
literature.  A boxplot was created to visually assess the difference among the three different 
ethnicities: Canadian-born Aboriginal, Canadian-born Non-Aboriginal, and Foreign-born (see 
Figure 6).  There is a very noticeable difference among the three ethnicities.  It is clear that 
Canadian-born Aboriginals have considerably higher housing densities than both Canadian-born 
Non-Aboriginal and Foreign-born.  Most Canadian-born Aboriginals lived in high density 
housing, whereas most Canadian-born Non-Aboriginals lived in low density housing.  This is a 
similar trend to what is reported in the literature (57).  The foreign-born population was split 
evenly between high density housing and low density housing.   
5.2 Research Question 1 
 
The association between nicotine concentration and cigarettes consumed per day was not 
linear, so a quadratic term was added.  The quadratic term reported cigarette consumption per 
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day was significantly associated with nicotine concentration.  Higher reported cigarette 
consumption meant a higher nicotine concentration was found in the hair, whereas a lower 
reported cigarette consumption meant a lower nicotine concentration was found.  It was expected 
that people who smoked more cigarettes would have a higher concentration of nicotine in their 
hair because they were exposed to more nicotine than people who smoked less or no cigarettes.  
Nevertheless, the last term in the quadratic equation (y=0.91+1.35x-0.25x2) was negative, 
suggesting that individuals who reported consuming more cigarettes a day may have incorrectly 
reported the number of cigarettes they consumed in a day.  Some individuals who smoked 
between 10-20 cigarettes a day had higher nicotine concentrations than individuals who smoked 
>30 cigarettes/day. This anomaly may have occurred for a few different reasons: it may have 
been an error in self-reporting cigarette consumption; it could also have been because these 
individuals smoked outside (this would decrease nicotine exposure); these individuals may 
smoke more per day, but inhale less nicotine due to the amount of nicotine in the cigarette or 
simply inhale less of the cigarette than others.  Moreover, certain levels of reported cigarette 
smoking cluster (as seen in Figure 7).  There was a lot of clustering amongst those smoking 10 
cigarettes/day.  This may be because 10 cigarettes/day is an easy estimate for people to report, 
especially if someone smokes less than a pack/day (approximately 25 cigarettes in a pack) and 
their cigarette consumption varies depending on the day.  They may also report 10 cigarettes/day 
if they are a heavier smoker (smoking pack/day), but want to present themselves as a “lighter” 
smoker due to social criticism.  
 47 
 
5.3 Research Question 2 
 
Among individuals who had a TB infection, no significant relationship was found 
between smokers and an increased risk of active TB when being compared to non-smokers.  
Only four individuals developed the outcome, meaning that finding a statistical association 
between the two variables was challenging.  The fact that three out of these four cases had 
previously developed TB ruled out identifying such a relationship.  Nevertheless, other studies 
have concluded that smokers have an increased likelihood of developing active TB than non-
smokers.  One meta-analysis estimated that smokers were 2.3-2.7 times more likely to develop 
active TB than non-smokers (45).  Another study looked a fairly large sample size (over 17,000 
participants) and found that smokers had a 1.94 more chance of developing active TB than non-
smokers when looking at individuals with positive TSTs (42).  This study did not have similar 
findings, but our sample size was also significantly smaller than most studies.  Moreover, active 
TB is something that takes time to develop, so future studies may want to have a longer 
timeframe in order to see who develops the outcome.  Because this study took place over 14 
months, data on development of active TB over time was limited. 
5.4 Research Question 3 
 
There was no statistically significant association between smoking and TB infection.  A 
larger sample size may have been able to provide a better understanding of a possible 
relationship.  Moreover, there was no statistically significant association between aboriginal 
status and TB infection. Nevertheless, the burden of TB in Canadian-born Aboriginals is much 
higher than the rest of the Canadian population.  It is estimated that in 2011, the overall rate of 
TB infection and disease among Canadian-born Aboriginals was nearly six times the Canadian 
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rate (58); this study did not have similar findings.  Once again, a larger sample size would have 
been able to give a better understanding of a possible relationship between Canadian-born 
Aboriginals and TB infection. 
5.5 Other Findings 
 
Working in the field on contact traces with the TB nurse proved to be a complicated task.  
Many people were difficult to contact, which made it especially difficult for the TB nurse to find 
certain individuals who were at higher risk of contracting TB.  Patience became the most 
important attribute when performing contract traces.  Some people would have a scheduled 
appointment with the TB nurse, but would not show up or answer their door.  It would then 
require the nurse to make another effort to find this person who needed to be tested.  It was 
equally important to be accommodating on contact traces.  This meant travelling a far distance or 
changing our schedule around just to be able to meet someone.  For future, bigger studies, it is 
recommended that active case finding be used (actively finding people who need to be tested, 
instead of them coming to those conducting the tests or being referred by a doctor).   
Alternatively, the consent rate was quite high among individuals who were asked to 
participate in this study.  This was very positive, as the interview and hair cutting process took 
time.  Many of the questions on the interview were quite sensitive.  The interview had to be 
approached with a very open mind and strong listening skills.  It is a notable finding that most 
individuals were quite comfortable with donating hair samples for the purpose of research 
(everyone who was asked to donate a hair sample complied). 
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5.6 Limitations 
 
Individuals asked to participate in this study were seen either in TB clinic or the field.  Of 
the individuals in this study, 83 (80%) were seen in the field and 21 (20%) were seen in the 
clinic.  Patients were brought to clinic because they were known to have a positive skin test, or 
they needed proper follow-up with one of the TB doctors.  Because of this, individuals who were 
seen in clinic were not randomly selected; this reduces the external validity of the study, meaning 
that our conclusions are less likely to apply to the general population.   
The cut-off for the TST was 5mm, which is the accepted practice among TB health 
professionals.  Nevertheless, a cut-off of 5mm, as opposed to 10mm or 15mm, lowers specificity 
and increases sensitivity.  A TST of 5mm could mean TB, but it may also be noise, such as a 
reaction to a previous vaccination.  A TST of 15mm is almost certainly TB, as this cut-off 
minimizes any noise that may occur. 
Thirteen individuals that were used in this study were found to have a previously positive 
recorded skin test.  This means our data was limited because we were unsure of their smoking 
status during their previous positive TST.  There was a section on the questionnaire dedicated to 
asking about past smoking history, but this was not the most accurate way to uncover past smoke 
exposure.  Ideally, a hair sample would have been obtained at the first recorded positive TST, as 
this would have been the most accurate way of examining smoke exposure.  For future studies, 
anyone who had a previous positive TST should not be eligible to participate in the study, unless 
a clear history of smoking and date of TST is provided.  
Second-hand smoke exposure was not well documented during the questionnaire.  Non-
smokers were asked how often they were exposed to the tobacco smoke of others, but not if they 
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live with a smoker.  Obtaining this information would have allowed us to compare non-smokers 
who live with smokers and smokers to see if there was a significant difference in TB infection 
between the two groups.  This may have provided some interesting insight into the affect second-
hand smoke has on TB infection/disease. 
HIV was a factor that affected a number of individuals in this study (9.5% of individuals, 
10/104).  HIV plays a significant confounder when looking at the development of TB.  This is 
because HIV is one of the strongest risk factors for developing TB disease.  In hindsight, 
individuals who knew they were HIV positive should have been omitted from participating in the 
study. 
Nearly half of the women in this study reported to dying their hair in the last six months.  
Research seems to be quite varied on the impact hair dye has on the uptake of nicotine 
concentration in hair.  One study examined the use of hair dye and concluded that the chemicals 
used for dying hair lowered nicotine and cotinine levels in hair, but do not completely eliminate 
them (49).   Another study looked at the effects of bleaching and hair dye on 8 samples of 
smokers. They found that the cuticle of the hair was not damaged after dying the hair, but that 
nicotine levels were reduced by 30% (49).  It appears that cosmetic treatment of the hair does 
affect the nicotine in the hair. In this study, we compared four groups in a boxplot: non-smokers 
who do not dye their hair, non-smokers who dye their hair, smokers who do not dye their hair, 
and smokers who dye their hair.  The comparison between the four groups suggests that there is a 
fairly significant difference in nicotine concentration levels between people who do and do not 
dye their hair.   
Another limitation of this study was the sample size.  The fact that only 104 subjects 
were recruited for this study really limited the amount of data and the associations that could be 
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made.  A smaller sample size also meant wider confidence intervals, which may have lowered 
the significance of any result.  It was difficult to calculate power analysis because the amount of 
people on contact traces, and how were available to be tested, varied throughout the year data 
was collected.  Looking towards future studies, more time is needed to recruit participants, so 
that a larger sample size can be obtained. 
5.7 Conclusion 
 
Tuberculosis (TB) has been a major threat to humans for a very long time. Smoking has 
been singled out as a risk factor for contracting TB infection and progression to TB disease.  
Despite numerous medical advances with tuberculosis in recent years, only a limited number of 
studies have examined the effect that active and passive smoking may have on contracting TB 
infection and progression to TB disease.  Even fewer studies have measured smoking with a 
method that does not completely rely on questionnaires.  One of the main strengths of this study 
is that it asked individuals how much they smoked and took a sample of their hair to get an exact 
idea of nicotine exposure. 
Although the sample size of this study was quite small compared to other studies looking 
for similar associations, there were a few interesting relationships that emerged from the data.    
The impact of hair dye on nicotine concentration was a relationship of interest.  It appeared that 
hair dye had a significant impact on nicotine concentration.  Reassuringly, there also appeared to 
be a strong association between reported cigarette consumption and nicotine concentration.  
Smoking and aboriginal status were not found to play a significant role in TB infection when 
building our full main effects model.  Moreover, there was no association between smoking and 
active TB found.  Lack of significance may have been caused from the small sample size. 
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Studies looking to build on this research will need a bigger sample size and to consider 
both HIV and hair treatment when gathering the data.  Additionally, collecting data over a longer 
period of time could potentially mean stronger associations, as development of TB may be more 
closely followed. 
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